SMALL CELL LUNG CANCER EXTENSIVE STAGE
Clinical trials for SMALL CELL LUNG CANCER EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lung cancer cocktail shows promise in early trial
Disease control OngoingThis study tests a new combination of chemotherapy drugs (paclitaxel and carboplatin) plus an immunotherapy drug (durvalumab) as a first treatment for people with extensive-stage small cell lung cancer. The goal is to see if this mix works better than the standard treatment. Abou…
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated May 26, 2026 06:59 UTC
-
New combo therapy aims to extend life in aggressive lung cancer
Disease control OngoingThis early-phase trial studies whether adding radiation to the chest followed by immunotherapy drugs (durvalumab alone or with tremelimumab or olaparib) can safely control extensive-stage small cell lung cancer after initial chemotherapy. About 25 adults whose cancer did not wors…
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 06:58 UTC
-
Engineered immune cells take aim at tough lung cancer
Disease control OngoingThis early-phase trial tests a new treatment called LB2102, which uses a patient's own immune cells (T-cells) that are modified in a lab to recognize and attack cancer cells that carry a protein called DLL3. The study includes about 41 adults with advanced small cell lung cancer …
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE1 • Sponsor: Legend Biotech USA Inc • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Triple-Drug attack shows promise against tough lung cancer
Disease control OngoingThis study tests a combination of two immunotherapy drugs (pembrolizumab and lenvatinib) plus standard chemotherapy in people with extensive-stage small cell lung cancer who have not had prior treatment. The goal is to see if this triple therapy is safe and can delay cancer growt…
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 18, 2026 12:13 UTC